USAspending · Contract award
AGIO: Department of Veterans Affairs contract award
PHARMACEUTICAL AQVESME - 3 MONTH SUPPLY.
Follow AGIO- First observed
- Nov 8, 2026, 6:30 PM EST
- Event / period date
- Jul 15, 2026
- Collected
- Nov 8, 2026, 6:30 PM EST
Why this is connected
Exact legal-name match: AGIOS PHARMACEUTICALS, INC. (https://www.sec.gov/Archives/edgar/data/1439222/).
Reported contract amount
$73,080.48
Source last modified: Jul 14, 2026
Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.
Source evidence
Read the source excerpt or record
{"internal_id":360208603,"Award ID":"36C26026F0349","Recipient Name":"AGIOS PHARMACEUTICALS, INC.","Award Amount":73080.48,"Description":"PHARMACEUTICAL AQVESME - 3 MONTH SUPPLY.","Awarding Agency":"Department of Veterans Affairs","Start Date":"2026-07-15","Last Modified Date":"2026-07-14 16:00:11","generated_internal_id":"CONT_AWD_36C26026F0349_3600_36F79725D0238_3600","awarding_agency_id":561,"agency_slug":"department-of-veterans-affairs"}Congressional trading in AGIO
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 10, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 7, 2026
- Jan 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Dec 11, 2025 · disclosed Jan 12, 2026
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Apr 17, 2025 · disclosed May 6, 2025
- Feb 11, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Jan 24, 2024 · disclosed Feb 15, 2024 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.